Amgen names Steven Galson, Senior Vice President, Global Regulatory Affairs and Safety

USA-based Amgen (Nasdaq: AMGN), the world's leading independent biotech firm, has announced the appointment of Steven Galson to the position of senior vice president, Global Regulatory Affairs and Safety, effective May 19. Mr Galson will report to Sean Harper executive vice president, Research and Development, and will be responsible for all regulatory and patient safety functions across Amgen.

Mr Galson joined Amgen as vice president of Global Regulatory Affairs in October 2010. He came to Amgen from Science Applications International Corporation, where he served as senior vice president for Civilian Health Operations and chief health scientist from October 2009 to October 2010.

Prior to that, Mr Galson had a distinguished 23-year career in United States Public Health Service. From 2001 to 2007, he served as deputy director and director of the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, where he provided leadership for the center's broad national and international programs in pharmaceutical regulation.